Inotropic Effects of Glyceryl Trinitrate and Spontaneous NO Donors in the Dog Heart

Circulation ◽  
1997 ◽  
Vol 96 (8) ◽  
pp. 2675-2682 ◽  
Author(s):  
Benedikt Preckel ◽  
Georg Kojda ◽  
Wolfgang Schlack ◽  
Dirk Ebel ◽  
Karin Kottenberg ◽  
...  
1983 ◽  
Vol 24 (2) ◽  
pp. 269-275 ◽  
Author(s):  
Shigetoshi CHIBA ◽  
Hidehiko WATANABE ◽  
Miyoharu KOBAYASHI
Keyword(s):  

1998 ◽  
Vol 76 (4) ◽  
pp. 435-439 ◽  
Author(s):  
Manoj Lakhe ◽  
Yasuyuki Furukawa ◽  
Takanori Yonezawa ◽  
Masamichi Hirose ◽  
Yoshito Nagashima ◽  
...  

2002 ◽  
Vol 80 (11) ◽  
pp. 1106-1118 ◽  
Author(s):  
Jodan D Ratz ◽  
Michael A Adams ◽  
Brian M Bennett

Animals treated with nitric oxide synthase (NOS) inhibitors exhibit marked hypersensitivity to the blood pressure lowering effects of exogenous nitric oxide (NO) donors. We used this model as a sensitive index to evaluate the relative importance of reduced biotransformation of glyceryl trinitrate (GTN) to NO in the development of nitrate tolerance. NOS-blockade hypertension using NG-nitro-L-arginine methyl ester (L-NAME) caused a marked enhancement of the mean arterial pressure (MAP) decrease mediated by GTN in nontolerant rats. However, even large doses of GTN were unable to change the MAP in GTN-tolerant, NOS-blockade hypertensive animals. In contrast, the MAP responses to the spontaneous NO donor sodium nitroprusside (SNP) were completely unaltered in either tolerant rats or tolerant NOS-blockade hypertensive animals, indicating that NO-dependent vasodilatory mechanisms remain intact despite the development of GTN tolerance. The MAP-lowering effects of GTN in NOS-blockade hypertensive animals were restored 48 h after cessation of chronic GTN exposure. These alterations in the pharmacodynamic response to GTN during tolerance development and reversal were associated with parallel changes in the pattern of GTN metabolite formation, suggesting that the activity of one or more enzymes involved in nitrate metabolism was altered as a consequence of chronic GTN exposure. These findings suggest that the vasodilation resulting from the vascular biotransformation of GTN to NO (or a closely related species) is severely compromised in nitrate-tolerant animals, and that although other mechanisms may contribute to the vascular changes observed following the development of GTN tolerance, decreased GTN bioactivation is likely the most important.Key words: biotransformation, glyceryl trinitrate, hypertension, nitric oxide, tolerance.


1978 ◽  
Vol 50 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Miyoharu Kobayashi ◽  
Yasuyuki Furukawa ◽  
Shigetoshi Chiba

1999 ◽  
Vol 518 (2) ◽  
pp. 449-461 ◽  
Author(s):  
Jean-Michel Chesnais ◽  
Rodolphe Fischmeister ◽  
Pierre-François Méry

1984 ◽  
Vol 25 (5) ◽  
pp. 793-803
Author(s):  
Shigetoshi CHIBA ◽  
Miyoharu KOBAYASHI ◽  
Masahiro SHIMOTORI ◽  
Yasuyuki FURUKAWA ◽  
Kimiaki SAEGUSA
Keyword(s):  

2016 ◽  
Vol 2016 ◽  
pp. 1-12 ◽  
Author(s):  
Philip M. Bath ◽  
Lisa Woodhouse ◽  
Kailash Krishnan ◽  
Craig Anderson ◽  
Eivind Berge ◽  
...  

Background.Nitric oxide (NO) donors are a candidate treatment for acute stroke and two trials have suggested that they might improve outcome if administered within 4–6 hours of stroke onset. We assessed the safety and efficacy of NO donors using individual patient data (IPD) from completed trials.Methods.Randomised controlled trials of NO donors in patients with acute or subacute stroke were identified and IPD sought from the trialists. The effect of NO donor versus control on functional outcome was assessed using the modified Rankin scale (mRS) and death, by time to randomisation. Secondary outcomes included measures of disability, mood, and quality of life.Results.Five trials (4,197 participants) were identified, all involving glyceryl trinitrate (GTN). Compared with control, GTN lowered blood pressure by 7.4/3.3 mmHg. At day 90, GTN did not alter any clinical measures. However, in 312 patients randomised within 6 hours of stroke onset, GTN was associated with beneficial shifts in the mRS (odds ratio (OR) 0.52, 95% confidence interval (CI) 0.34–0.78) and reduced death (OR 0.32, 95% CI 0.14–0.78).Conclusions.NO donors do not alter outcome in patients with recent stroke. However, when administered within 6 hours, NO donors might improve outcomes in both ischaemic and haemorrhagic stroke.


Sign in / Sign up

Export Citation Format

Share Document